Conclusions inconsistent with results with citalopram.
Kruszewski
Stefan P
SP
D000367:Age Factors; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D015283:Citalopram / Q000627:therapeutic use*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D008297:Male; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic / Q000592:standards / Q000706:statistics & numerical data; D012107:Research Design / Q000592:standards*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013223:Statistics as Topic; D016896:Treatment Outcome
D015283:Citalopram; D008140:Lorazepam; D010919:Placebos; D017367:Selective Serotonin Reuptake Inhibitors